The Lockwood Group Welcomes IDEOlogy Health - Accelerating its Leadership Role in Community Oncology
STAMFORD, Conn., May 12, 2025 /PRNewswire/ -- The Lockwood Group, a global pharma services organization, announced today the acquisition of IDEOlogy Health, based in Austin, TX, a best-in-class omnichannel medical education company known for its innovative engagement platforms and strategic healthcare provider communications tools. The acquisition strengthens The Lockwood Group's commitment to delivering data-driven, high-impact medical strategy and communications for life science companies worldwide.
This strategic move combines The Lockwood Group's deep scientific expertise and integrated services with IDEOlogy Health's proprietary non-promotional educational solutions and strong reputation in oncology and hematology—including exclusive community oncology partnerships. Together, the unified organization will offer clients expanded capabilities, enhanced digital engagement tools, and greater scale across all facets of medical communications.
'We are thrilled to welcome IDEOlogy Health to the Lockwood team,' said Matthew Schecter, Founder & CEO of The Lockwood Group. 'Their culture of innovation, scientific rigor, and unique engagement tools are a perfect complement to our strategic vision. This partnership accelerates our ability to offer differentiated value to our clients and deepens our impact on healthcare providers and, ultimately, patients. We look forward to working alongside Mike Gramling (founder IDEOlogy Health), Cameron Lush, PhD (President), and their team as they continue to execute on their vision while leveraging The Lockwood Group's strong operational success and history'
The integration of IDEOlogy Health's technology platforms—including IDEO Talks and Sound Bites—into The Lockwood Group's offering will enable more personalized, data-driven engagement strategies for clients navigating increasingly complex therapeutic landscapes. Additionally, this acquisition positions The Lockwood Group for continued growth in the oncology and rare disease sectors.
'This is an exciting new chapter for IDEOlogy Health,' said Mike Gramling, 'Joining forces with The Lockwood Group allows us to scale our impact, expand our reach, and elevate the work we do with our clients and our partners in community oncology. Together, we're poised to redefine what excellence in medical communications looks like.'
Jefferies acted as exclusive financial advisor to IDEOlogy Health.
About The Lockwood Group
The Lockwood Group is a global pharma services organization with over 600 employees, that partners with pharmaceutical and biotechnology companies to translate complex science into compelling strategies that drive clinical and commercial success. Learn more at www.thelockwoodgrp.com.
About IDEOlogy Health
IDEOlogy Health's unique strategic collaborations with leading community oncology partners allow them to build customized multichannel medical communications that are unique to their networks. Additionally, IDEOlogy Health is host to multiple congresses including the CME-accredited Texas Lung Cancer Conference, World Conference on Genitourinary Cancers, and the Nashville Hematology Conference. IDEOlogy Health's platforms are known for driving measurable impact in specialty medicine. Learn more at www.ideologyhealth.com.
CONTACTS:
The Lockwood Group
[email protected]
203-883-8747
View original content to download multimedia: https://www.prnewswire.com/news-releases/the-lockwood-group-welcomes-ideology-health---accelerating-its-leadership-role-in-community-oncology-302452522.html
SOURCE The Lockwood Group
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
14 minutes ago
- Washington Post
FAA nominee tells senators he will modernize air traffic control system
Bryan Bedford, President Donald Trump's nominee to lead the Federal Aviation Administration, told a Senate panel on Wednesday that if confirmed, he will push the agency to act with urgency on the administration's multi-billion-dollar revamp of the nation's air traffic control system. 'I know change can be hard, but I believe the agency can get back on the right track,' Bedford told members of the Senate Commerce, Science and Transportation Committee at his confirmation hearing on Wednesday. Bedford, 63, the CEO of regional carrier Republic Airways, acknowledged that public confidence in the safety of the nation's airspace has been rattled this year by the midair collision near Reagan National Airport that killed 67 people, as well as by equipment failures that caused thousands of delays and cancellations at Newark Liberty International Airport. He said he is committed to rebuilding trust in the agency, which has seen an exodus of veteran leaders as part of staff reductions championed by the U.S. DOGE Service. 'The FAA is sorely in need of his steady leadership,' said Sen. Ted Cruz (R-Texas), the committee's chairman. 'No Senate-confirmed head of the agency completed a full five-year term since 2018.' The agency has seen a parade of permanent and acting leaders in recent years, which some analysts and lawmakers think has hampered its ability to move forward on efforts to tackle decades-old problems including the persistent shortage of air traffic controllers. The FAA's last permanent leader, Michael Whitaker, stepped down in January after just over a year in the job. Bedford told lawmakers he is committed to serving out his full five-year term. Bedford pledged to 'to build a new best-in-class air traffic control system and to rectify the chronic understaffing in our nation's air centers. However, to accomplish this, I hope we can agree we can't repeat the mistakes of the past. We can't accept half measures.' In response to written questions from the committee, Bedford signaled that he would not hesitate to shake up an agency that he views as too cautious and risk-averse. 'There appears to be no incentive for anyone at FAA to take any innovation risk for fear that it could fail,' he wrote. 'You could say there was an 'if it ain't broke, don't fix it' attitude, but that has morphed into a quiet resignation that 'we can't fix it, but we can do our very best to make the system work safely today' mindset.' Bedford said as a result a 'malaise' has set in at the FAA, where 'managers believe the agency is helpless to make the necessary changes, and furthermore, they rationalize it isn't really their fault,' he continued. 'The best they can do is fight every day to make the current system limp along safely.' Bedford has served as CEO of Republic Airways, a regional carrier based in Indianapolis, since 1999. He is married with nine children, several of which joined him at Wednesday's hearing. He has a bachelor's degree in business from Florida State University. Bedford has won praise from an array of industry groups, with Airlines for America, the trade group that represents the nation's largest carriers, calling him a 'superb choice' to lead the agency. 'He intimately understands the importance of a strong working relationship between the FAA and airspace operators of all sizes,' the group said in a statement, urging the Senate committee to move quickly to confirm him. But his nomination has drawn opposition from Democrats on the panel and some labor unions, including the Air Line Pilots Association, which cited his support of efforts to reduce the number of flight hours required to become a commercial pilot. Though repeatedly pressed by several Democratic senators about whether he would seek to reduce the current 1,500-hour requirement, Bedford would only say that he would not take any action that would compromise safety. 'It's important that we have an FAA administrator who strengthens our aviation standards to honor the families who have lost loved ones in these tragic accidents,' said Sen. Maria Cantwell (Washington), the committee's ranking Democrat. 'The tragic midair collision in January between the Army Blackhawk helicopter and American Airlines Flight 5342 took the lives of 67 people and is a stark reminder of what happens when the system fails.'
WebMD
15 minutes ago
- WebMD
Dense Breast Tissue Can Hide Cancer. Now What?
June 11, 2025 — Have you checked your annual mammogram off your health to-do list? That's a relief, for sure — but there's one more critical step to take after you get your results. Go over your report to see if you have dense breast tissue. For more than 40% of women, the answer is yes. And that means you may want to consider supplemental testing. The next step isn't always clear. But two new studies compared your options. Here's what to know. 1. Having dense breasts increases your risk of breast cancer. Why it matters: Not only is the risk higher, but it's also harder to detect cancer in dense breasts. What to know: Dense breasts have more fibrous tissue and milk glands than fat tissue. On a mammogram, the dense areas show up as white — the same color as cancer. That can make cancer harder to see, particularly when it's small. Federal law (since last fall) requires that you be notified whether your mammogram shows you have dense breasts. To be certain, check your patient portal report or call your doctor's office. You'll also want to find out if you have 'heterogeneously dense' or 'extremely dense' breasts. What's the difference? "Heterogeneously dense" means most of the breast is dense with some areas of fat, and "extremely dense" means the breast has almost no fatty tissue. Even if you don't have dense breasts now, they could become more dense as you age, so you need to recheck your report every year. Dense breasts can only be diagnosed with imaging — a physical exam can't tell. Bottom line: 'Women should know that if they have dense breasts, the mammogram might not see their cancer,' said Ruth Etzioni, PhD, a biostatistician at Fred Hutchinson Cancer Center in Seattle who specializes in analyzing benefit-harm tradeoffs in cancer screening tests. 2. If you have dense breasts, consider supplemental screening. Why it matters: Between 25% and 30% of cancers in heterogeneously dense breasts are missed on a standard mammogram. That number for extremely dense breasts is even higher, potentially topping 40%. What to know: Knowing your breast density type can help you understand how likely a mammogram would be to miss cancer in your breast. But that's only one part of the decision-making equation. For those with heterogeneously dense breasts, 'we typically will consider other risk factors in addition to breast density in order to decide whether to recommend supplemental screening,' said Pittsburgh-based radiologist and dense-breast expert Wendie A. Berg, MD, PhD. A list of risk factors, including family history and high BMI after menopause, is available at Bottom line: If you have extremely dense breasts, you should get supplemental screening, Berg said. If you have heterogeneously dense breasts, you should know your risk factors and talk to your doctor about what makes sense for you. 3. There are three types of supplemental screenings. Why it matters: Researchers compared these techniques — ultrasound, MRI, and contrast-enhanced mammogram — by randomly assigning them to women ages 50 to 70 with dense breasts whose mammograms didn't detect cancer. Results showed that MRI and the contrast-enhanced mammogram (using an iodine -based dye that helps reveal cancers) each found nearly five times as many cancers as ultrasound. What to know: Contrast-enhanced mammogram detected 19.2 cancers per 1,000 people scanned; MRI detected 17.4 per 1,000 scans; ultrasound detected 4.2 per 1,000. These detection rates were somewhat higher than in past studies, Berg and Etzioni said. They noted that women who get the scans repeated annually often see those detection rates drop over time. (That's because you're more likely to have an undetected past cancer than to develop a new one in the next year.) A separate study in JAMA Oncology recently showed that among women with a family history of breast cancer, just getting a slightly better scan than a standard mammogram — called a 3D mammogram — offered improved detection of advanced cancer in women with extremely dense breasts. 'That was compelling that we should really be doing [3D mammogram] as the routine screening, at least for the basic screening,' Berg said. Bottom line: If you have a family history of breast cancer, request a 3D mammogram for your initial annual screen, and when considering supplemental scans, know that some are better than others. 4. Your doctor may not automatically suggest supplemental screening. Why it matters: Berg's own doctor questioned her request to get an MRI after Berg learned that she has dense breasts. Ultimately, she got the MRI, which showed a small cancer that she said was easily treated and she has recovered. What to know: An advisory group called the U.S. Preventative Services Task Force that typically influences what insurance will cover doesn't recommend supplemental screening for people with dense breasts. Their reason: There is no multi-year clinical trial data examining whether extra screenings have drawbacks. Bottom line: It's OK to request supplemental screening, and knowing your risk factors will help during that conversation with your doctor. 'You still can't count on your doctor to provide all the information that you might need to make a decision for yourself about supplemental screening,' Berg said. 5. Not all supplemental screenings are covered by insurance. Why it matters: Not every state requires insurance to cover supplemental screenings — and in those that do, the law may not apply to every type of insurance. maintains a list of which states and plan types are required to cover it. What to know: Without coverage, out-of-pocket costs for an MRI can reach thousands of dollars, but a type called 'abbreviated' or 'quick' MRI can be lower — between $300 and $600 total. Contrast mammography and ultrasound are usually even less, and a 3D mammogram can sometimes cost an extra $40 or $50. MRIs where Berg works in Pittsburgh are booking six months out. A contrast-enhanced mammogram isn't a usual method used in the U.S., but Berg said some places are starting to offer it and testing the waters to see if insurance will cover it. The procedure only takes about 15 minutes, including the contrast dye injection, and uses a standard mammogram machine. Bottom line: 'If you have heterogeneously dense breasts, I think it really does come down to your own tolerance of other risk factors and whether your insurance will cover it, so it is more of a personal choice,' Berg said. 6. Think through your benefit/harm tradeoffs. Why it matters: Getting extra scans can be stressful, potentially expensive, and require a lot of time researching and communicating with your provider — not to mention taking time off work for appointments. What to know: Your risk calculation is complex, including the risk of missing a cancer detection. For example, ultrasound does have advantages (it's quick, noninvasive, and inexpensive), but tends not to spot cancer until the tumor is larger. There's also about a 10% risk of a false positive with most screening types. 'You have to poke a lot of people to find the people that you can help,' said Etzioni, who is an expert in data-driven medical decision-making, particularly when it comes to diagnostic testing and early cancer diagnosis. Bottom line: Deciding whether to get additional screening is personal and involves weighing your comfort with risk and the potential stress and cost of a false positive, Berg said. 'I think it's hard — you don't want to have any regrets either way. I don't know anybody who has regrets that their cancer was found too small. It's always better — if it's going to be there — to find it as early as possible.'
The Verge
16 minutes ago
- The Verge
Posted Jun 11, 2025 at 4:51 PM EDT 0 Comments
Google has appointed a chief AI architect. Koray Kavukcuoglu, Google DeepMind's chief technology officer, will work to combine Google's AI models with its products 'with the goal of more seamless integration, faster iteration, and greater efficiency,' according to a memo seen by Semafor. Kavukcuoglu will reportedly remain Google DeepMind CTO while in his new role.
